Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment

OBJECTIVE: The ideal endpoint of antiviral therapy in chronic hepatitis B (CHB) patients is to clear hepatitis B surface antigen (HBsAg). This study aimed to evaluate whether the expression of functional molecules on plasmacytoid dendritic cells (pDCs) is associated with HBsAg loss in HBeAg-positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Weihua, Xie, Si, Zhang, Lu, Bi, Xiaoyue, Lin, Yanjie, Yang, Liu, Lu, Yao, Liu, Ruyu, Chang, Min, Wu, Shuling, Shen, Ge, Dong, Jianping, Xie, Yao, Li, Minghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160736/
https://www.ncbi.nlm.nih.gov/pubmed/35663955
http://dx.doi.org/10.3389/fimmu.2022.891424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160736/
https://www.ncbi.nlm.nih.gov/pubmed/35663955
http://dx.doi.org/10.3389/fimmu.2022.891424

Ejemplares similares